Cancer Medicine

Article	Citations
Prognostic significance of T‐cell–inflamed gene expression profile and PD‐L1 expression in patients with esophageal cancer	95
Current treatment and surveillance modalities are not sufficient for advanced stage III colon cancer: Result from a multicenter cohort analysis	95
Inequalities in survival and care across social determinants of health in a cohort of advanced lung cancer patients in Quebec (Canada): A high‐resolution population‐level analysis	94
The genomic landscape of teenage and young adult T‐cell acute lymphoblastic leukemia	84
Compliance to genomic test recommendations to guide adjuvant chemotherapy decision‐making in the case of hormone receptor‐positive, human epidermal growth factor receptor 2‐negative breast cancer, in	82
FDG uptake reflects an immune‐enriched subtype of thyroid cancer: Clinical implications of imaging‐based molecular characterization	79
The rare entity of gastrointestinal leiomyosarcomas: An Italian multicenter retrospective study in high‐volume referral centers	79
Clinical outcome assessment trends in clinical trials—Contrasting oncology and non‐oncology trials	73
Effectiveness of various human papillomavirus vaccination strategies: A community randomized trial in Finland	66
Predicting anxiety in cancer survivors presenting to primary care – A machine learning approach accounting for physical comorbidity	61
Inhibition of FGFR3 upregulates MHC‐I and PD‐L1 via TLR3/NF‐kB pathway in muscle‐invasive bladder cancer	57
Is tumor necrosis a clinical prognostic factor in hepato‐biliary‐pancreatic cancers? A systematic review and meta‐analysis	55
Identification of a genetic signature enriching for response to ibrutinib in relapsed/refractory follicular lymphoma in the DAWN phase 2 trial	54
Clinical value of endoscopic ultrasound sound speed in differential diagnosis of pancreatic solid lesion and prognosis of pancreatic cancer	52
Comprehensive analysis indicated that NDE1 is a potential biomarker for pan‐cancer and promotes bladder cancer progression	44
Combination tumor‐treating fields treatment for patients with metastatic non‐small cell lung cancer: A cost‐effectiveness analysis	44
Glycemic traits and colorectal cancer survival in a cohort of South Korean patients: A Mendelian randomization analysis	44
MYCN amplification plus 1p36 loss of heterozygosity predicts ultra high risk in bone marrow metastatic neuroblastoma	43
Characteristics of endoplasmic reticulum stress in colorectal cancer for predicting prognosis and developing treatment options	43
Clinical characteristics, tumor‐infiltrating lymphocytes, and prognosis in HER2‐low breast cancer: A comparison study with HER2‐zero and HER2‐positive disease	43
Issue Information	42
CDK5 positively regulates Notch1 signaling in pancreatic cancer cells by phosphorylation	42
Autologous menisci–cruciate ligament composite as a flap for soft tissue reconstruction following malignant bone tumor resection around the knee	41
It is not the time to abandon intraoperative frozen section in endometrioid adenocarcinoma: A large‐scale, multi‐center, and retrospective study	40
Characterization of the gene signature correlated with favorable response to chemoradiotherapy in rectal cancer: A hypothesis‐generating study	40

Insulin‐like growth factor binding protein‐2 and glucose‐regulated protein 78 kDa: Potential biomarkers affect prognosis in IDH‐wildtype glioblastoma patients	38
Cover Image	38
	38
Treatments, prognostic factors, and genetic heterogeneity in advanced cholangiocarcinoma: A multicenter real‐world study	37
Radiation enteropathy‐related depression: A neglectable course of disease by gut bacterial dysbiosis	37
Issue Information	37
Treatment patterns and clinical outcomes of chidamide combined with endocrine therapy in hormone receptor‐positive, HER2‐negative metastatic breast cancer: A real‐world multicenter study	37
Pivotal role of myeloid‐derived suppressor cells in infection‐related tumor growth	36
Enrichment of Cancer‐Associated Fibroblasts, Macrophages, and Up‐Regulated TNF‐α Signaling in the Tumor Microenvironment of CMS4 Colorectal Peritoneal Metastasis	36
Exploring Multiplex Immunohistochemistry (mIHC) Techniques and Histopathology Image Analysis: Current Practice and Potential for Clinical Incorporation	35
Repurposing of Metformin to Improve Survival Outcomes in Patients With Upper Tract Urothelial Carcinoma	35
Differentiating Pulmonary Nodule Malignancy Using Exhaled Volatile Organic Compounds: A Prospective Observational Study	35
Arterial Thromboembolism in Patients With Advanced Lung Cancer: Secondary Analyses of the Rising‐VTE/NEJ037 Study	35
Trends in novel antiandrogen receptor signal inhibitor use and medical costs in prostate cancer	34
The Association Between Body Composition, Overall Survival, Treatment Decisions, and Patient‐Reported Outcomes in Metastatic Non‐Small‐Cell Lung Cancer	34
Real‐World Prevalence, Treatment Patterns, and Outcomes for Patients With HER2 (ERBB2)‐Mutant Metastatic Non‐Small Cell Lung Cancer, From a US‐Based Clinico‐Genomic Database	34
Patient and Caregiver Perceptions of Caregiving Contributions During Cancer Clinical Trials: A Mixed‐Methods Study	34
Short‐Course Blinatumomab Treatment as a Bridge to Further Salvage Therapy for Relapsed/Refractory B‐Cell Acute Lymphoblastic Leukemia: A Retrospective Single‐Center Study	34
	34
Immunoinfiltration Analysis of Mitochondrial Damage‐Related Genes in Lung Adenocarcinoma and Construction of a Classification and Prognostic Model Integrated With WGCNA and Machine Learning	33
The MIR181A2HG/miR‐5680/VCAN‐CD44 Axis Regulates Gastric Cancer Lymph Node Metastasis by Promoting M2 Macrophage Polarization	33
A Mitochondria‐Related Signature in Diffuse Large B‐Cell Lymphoma: Prognosis, Immune and Therapeutic Features	33
Activin A promoted the anti‐tumor effect of ActRIIA high CD8+ T cells in mouse hepatoma	33
Macrophage Infiltration and ITGB2 Expression in ESCC: A Novel Correlation	32
Drivers of Palliative Care and Hospice Use Among Patients With Advanced Lung Cancer	32
Evaluation of Treatment Outcomes Using dNLR and GNRI in Combination Therapy With Atezolizumab and Bevacizumab for Hepatocellular Carcinoma	32
Deciphering the Differences Between Epstein–Barr Virus‐Associated and Negative Gastric Cancer in the Prospect of CDKN2A Genomic Alterations and Lymphoid Infiltration	32
Mammography Among Women Residing in Urban Versus Rural Utah: Breast Cancer Survival	31
Molecular Mechanisms of Synergistic Effect of PRIMA‐1met and Oxaliplatin in Colorectal Cancer With Different p53 Status	31
The Effect of Expressive Writing on the Experiences of Head and Neck Cancer Patients Undergoing Radiotherapy: A Randomized Controlled Trial	31
Encapsulated papillary carcinoma of the breast: An institutional case series and literature review	29
Comprehensive analysis of the prognostic and role in immune cell infiltration of MSR1 expression in lower‐grade gliomas	29
Patient perspectives of weight stigma across the cancer continuum: A scoping review	29
A simple test‐based frailty index to predict survival among cancer patients with an unplanned hospitalization: An observational cohort study	29
Development and validation of a novel nomogram predicting clinically significant prostate cancer in biopsy‐naive men based on multi‐institutional analysis	29
Ginsenoside Rh2 attenuates the progression of non‐small cell lung cancer by sponging miR‐28‐5p/STK4 axis and inactivating Wnt/β‐catenin signaling	29
Acute patient‐reported outcomes in B‐cell malignancies treated with axicabtagene ciloleucel	28
Impact of reproductive factors on breast cancer incidence: Pooled analysis of nine cohort studies in Japan	28
Perspectives surrounding fertility preservation and posthumous reproduction for adolescent and young adults with terminal cancer: Survey of allied health professionals	28
Depleting the 19S proteasome regulatory PSMD1 subunit as a cancer therapy strategy	28
Worsened outcomes of newly diagnosed cancer in patients with recent emergency care visits: A retrospective cohort study of 3699 adults in a safety net health system	28
Dynamics of disease progression during treatment with Osimertinib in patients with EGFR T790M‐positive non‐small cell lung cancer	28
Use of multikinase inhibitors/lenvatinib concomitant with radioiodine for the treatment of radioiodine refractory differentiated thyroid cancer	28
LncRNA BCLET variant confers bladder cancer susceptibility through alternative splicing of MSANTD2 exon 1	28
Conditional survival in breast cancer up to 10 years in the Nordic countries	27
Exercise during chemotherapy: Friend or foe?	27
Genetically predicted 486 blood metabolites in relation to risk of colorectal cancer: A Mendelian randomization study	27
Protein disulphide isomerase inhibition as a potential cancer therapeutic strategy	27
Efficacy of fusion imaging for immediate post‐ablation assessment of malignant liver neoplasms: A systematic review	27
Cardiotoxicity screening of long‐term, breast cancer survivors—The CAROLE (Cardiac‐Related Oncologic Late Effects) Study	26

Physical activity, polygenic risk score, and colorectal cancer risk	26
Skull defect increases the tumor treating fields strength without detrimental thermogenic effect: A computational simulating research	26
Impact of high neutrophil‐to‐lymphocyte ratio on survival in hospitalized cancer patients with COVID‐19	26
Exosomal TUBB3 mRNA expression of metastatic castration‐resistant prostate cancer patients: Association with patient outcome under abiraterone	26
A screening assistance system for cervical cytology of squamous cell atypia based on a two‐step combined CNN algorithm with label smoothing	26
Assessment of the efficacy and tolerability of ruxolitinib for the treatment of myelofibrosis patients in a real‐life setting: An Italian MYNERVA Project	26
Reciprocal interactions among Cobll1, PACSIN2, and SH3BP1 regulate drug resistance in chronic myeloid leukemia	25
Deconvolution of bulk gene expression profiles reveals the association between immune cell polarization and the prognosis of hepatocellular carcinoma patients	25
Cover Image	25
Issue Information	25
Development of a nutritional screening and assessment indicator system for patients with esophageal cancer in China: Findings from the Delphi method	24
Reduced expression of alanyl aminopeptidase is a robust biomarker of non‐familial adenomatous polyposis and non‐hereditary nonpolyposis colorectal cancer syndrome early‐onset colorectal cancer	24
Cigarette smoke condensate induces centrosome clustering in normal lung epithelial cells	24
MDSC suppresses T cell antitumor immunity in CAC via GPNMB in a MyD88‐dependent manner	24
Five‐year survival post hepatectomy for colorectal liver metastases in a real‐world Chinese cohort: Recurrence patterns and prediction for potential cure	24
Adipose tissue area is a predictive biomarker for the efficacy of pegylated liposomal doxorubicin in platinum‐refractory/resistant ovarian cancer	23
Impact of race‐specific screening guideline on the uptake of colorectal cancer screening among young African Americans	23
Re‐irradiation in patients with progressive or recurrent brain metastases from extracranial solid tumors: A novel prognostic index	23
KIAA1429 mediates epithelial mesenchymal transition in sorafenib‐resistant hepatocellular carcinoma through m6A methylation modification	23
Sociodemographic and clinical factors associated with receipt of biomarker testing in patients with metastatic colorectal cancer	23
HTLV‐1 Tax‐specific memory cytotoxic T lymphocytes in long‐term survivors of aggressive‐type adult T‐cell leukemia/lymphoma	23
Socioeconomic determinants are associated with the utilization and outcomes of active surveillance or watchful waiting in favorable‐risk prostate cancer	23
Association of blood cell‐based inflammatory markers with gut microbiota and cancer incidence in the Rotterdam study	23
Prediction value with a novel and accurate tissue‐based human papillomavirus detection method in low‐grade squamous intraepithelial lesions	23
Kidney‐sparing surgery for distal high‐risk ureteral carcinoma: Clinical efficacy and preliminary experiences in 22 patients	23
A survey of carboplatin desensitization therapy in Japan: A multicenter retrospective study	23
Characterization of RNA modifications in gastric cancer to identify prognosis‐relevant gene signatures	23
Diagnostic accuracy of serum protein induced by vitamin K absence (PIVKA‐II), serum a‐fetoprotein and their combination for hepatocellular carcinoma among Caucasian cirrhotic patients with diagnostic	23
Inhibition of lncRNA PCAT19 promotes breast cancer proliferation	23
Fertility counselling and fertility preservation among early onset female cancer patients—A Finnish register‐based study	22
Association of area‐level mortgage denial and guideline‐concordant non‐small‐cell lung cancer care and outcomes in the United States	22
Clinical implications of using both fluoropyrimidine and paclitaxel in patients with severe peritoneal metastasis of gastric cancer: A post hoc study of JCOG1108/WJOG7312G	22
CCNI2 plays a promoting role in the progression of colorectal cancer	22
Machine learning‐based model constructed from ultrasound radiomics and clinical features for predicting HER2 status in breast cancer patients with indeterminate (2+) immunohistochemical results	22
Establishing a robust radioligand therapy program: A practical approach for North American centers	22
	22
Development of the CK‐MB‐1 trastuzumab‐resistant HER2‐positive breast cancer cell line and xenograft animal models	22
Neurocognitive and psychosocial outcomes in survivors of childhood leukemia with Down syndrome	22
Healthcare costs of cancer among children, adolescents, and young adults: A scoping review	22
Educational outcomes in siblings of childhood leukemia survivors: Factors associated with school difficulties and comparison with general population	22
Real world clinicopathologic observations of patients with metastatic solid tumors receiving immune checkpoint inhibitor therapy: Analysis from Kentucky Cancer Registry	22
Clinicopathological comparison between PTCL‐TBX21 and PTCL‐GATA3 in Japanese patients	22
An international multicenter study comparing COVID‐19 omicron outcomes in patients with hematological malignancies treated with obinutuzumab versus rituximab	21
Misuse of tumor marker levels leads to an insufficient International Germ Cell Consensus Classification (IGCCCG) risk group assignment and impaired treatment	21
Semen and serum platinum levels in cisplatin‐treated survivors of germ cell cancer	21
Impact of the COVID‐19 pandemic on the in‐hospital diagnostic pathway of breast and colorectal cancer in the Netherlands: A population‐based study	21
Incidence and prognostic impact of U2AF1 mutations and other gene alterations in myelodysplastic neoplasms with isolated 20q deletion	21
Issue Information	21
IMMUNOREACT 0: Biopsy‐based immune biomarkers as predictors of response to neoadjuvant therapy for rectal cancer—A systematic review and meta‐analysis	21
Linguistic analysis of plain language summaries and corresponding scientific summaries of Cochrane systematic reviews about oncology interventions	21
Issue Information	20
Application of computer‐aided detection for NCCN‐based follow‐up recommendation in subsolid nodules: Effect on inter‐observer agreement	20
The feasibility and effects of a pharmacological treatment algorithm for cancer patients with terminal dyspnea: A multicenter cohort study	20
Development and validation of a cost‐effective virtual reality educational tool to reduce anxiety and improve set‐up accuracy in radiotherapy patients	20
Issue Information	20
The survival benefit of increasing the number of active drugs for metastatic colorectal cancer: A multicenter retrospective study	20
The role of sex and rurality in cancer fatalistic beliefs and cancer screening utilization in Florida	20
	20
Cancer and the family: Variations by sex and race/ethnicity	20
Comparison of percutaneous ablation and hepatectomy for liver metastasis: A single center retrospective study	20
Safety and efficacy of atezolizumab plus bevacizumab in elderly patients with hepatocellular carcinoma: A multicenter analysis	20
Poor association between dihydropyrimidine dehydrogenase (DPYD) genotype and fluoropyrimidine‐induced toxicity in an Asian population	20
Efficiency of transurethral en‐bloc resection vs. conventional transurethral resection for non‐muscle‐invasive bladder cancer: An umbrella review	19
The real‐world clinical outcomes and treatment patterns of patients with unresectable locally advanced or metastatic soft tissue sarcoma treated with anlotinib in the post‐ALTER0203 trial e	19
Prevalence of frailty and prediction of mortality in Chinese cancer patients using a frailty index‐based clinical algorithm—A multicentre study	19
Association between F‐box‐only protein 43 overexpression and hepatocellular carcinoma pathogenesis and prognosis	19
Issue Information	19
Defining and targeting macrophage heterogeneity in the mammary gland and breast cancer	19
Feasibility of supervised telehealth exercise for patients with advanced melanoma receiving checkpoint inhibitor therapy	19
Active involvement of patients, radiation oncologists, and surgeons in a multidisciplinary team approach: Guiding local therapy in recurrent, metastatic rectal cancer	19
Cover Image	19
Exosome‐related lncRNA score: A value‐based individual treatment strategy for predicting the response to immunotherapy in clear cell renal cell carcinoma	19
The cancer survival index—A prognostic score integrating psychosocial and biological factors in patients diagnosed with cancer or haematologic malignancies	19
PD‐L1 expression is associated with the spontaneous regression of patients with methotrexate‐associated lymphoproliferative disorders	19
Pain experience of lung cancer patients during home recovery after surgery: A qualitative descriptive study	18
BMI changes and the risk of lung cancer in male never‐smokers: A prospective cohort study	18
Risk factors and prognostic factors for pulmonary large cell neuroendocrine carcinoma with brain metastasis	18
Genomic alteration profile and PD‐L1 expression among different breast cancer subtypes in Chinese population and their correlations	18
Malic enzyme 2 promotes the progression of hepatocellular carcinoma via increasing triglyceride production	18
Neoadjuvant androgen deprivation therapy combined with abiraterone acetate in patients with locally advanced or metastatic prostate cancer: When to perform radical prostatectomy?	18

Genetic ancestry, differential gene expression, and survival in pediatric B‐cell acute lymphoblastic leukemia	18
Molecular genetic and clinical characteristic analysis of primary signet ring cell carcinoma of urinary bladder identified by a novel OR2L5 mutation	18
Cancer screening in people living with HIV	18
Severe anaphylaxis caused by intravenous anti‐cancer drugs	18
Clinical results of active surveillance for extra‐abdominal desmoid‐type fibromatosis	18
Comparison of model fit and discriminatory ability of M category as defined by the 7th and 8th editions of the tumor‐node‐metastasis classification of colorectal cancer and the 9th edition of the Japa	17
Health‐related quality of life and survival outcomes for patients with major depressive disorder and anxiety: A longitudinal study in pancreatic ductal adenocarcinoma	17
Automated analysis of computerized morphological features of cell clusters associated with malignancy on bile duct brushing whole slide images	17
	17
Nicotinamide N‐methyltransferase is related to MELF pattern invasion in endometrioid carcinoma	17
Cover Image	17
Race‐specific prostate cancer outcomes in a cohort of military health care beneficiaries undergoing surgery: 1990–2017	17
Pancreatic adenosquamous carcinoma: A population level analysis of epidemiological trends and prognosis	17
Impact of genomic testing on urologists' treatment preference in favorable risk prostate cancer: A randomized trial	17
Inflammatory geriatric nutritional risk index stratified the survival of older adults with cancer sarcopenia	17
Clinical outcomes for patients with thymoma and thymic carcinoma after undergoing different front‐line chemotherapy regimens	17
Prognostic models for early and late tumor progression prediction in nasopharyngeal carcinoma: An analysis of 8292 endemic cases	17
Association between PD‐1 inhibitor‐related adverse events and frailty assessed by frailty index in lung cancer patients	17
	17
The effect of chronic viral hepatitis on prognostic value of inflammatory biomarkers in hepatocellular carcinoma	17
SALL4 correlates with proliferation, metastasis, and poor prognosis in prostate cancer by affecting MAPK pathway	17
Immune checkpoint gene VSIR predicts patient prognosis in acute myeloid leukemia and myelodysplastic syndromes	17
Risk of cardiovascular disease in cancer survivors: A cohort study of 446,384 New Zealand primary care patients	17
Do breast cancer survivors with a recent history of clinical depression report worse experiences with care? A retrospective cohort study using SEER‐CAHPS data	17
Expression of PTGS2 along with genes regulating VEGF signalling pathway and association with high‐risk factors in locally advanced oral squamous cell carcinoma	17
Real‑world survival outcome comparing abiraterone acetate plus prednisone and enzalutamide for nonmetastatic castration‐resistant prostate cancer	17
Optimizing induction chemotherapy regimens for radiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma	17
Provider‐ and patient‐level predictors of oral anticancer agent initiation and adherence in patients with metastatic renal cell carcinoma	17
National variation in the delivery of radiation oncology procedures in the non‐facility‐based setting	17
Traditional Chinese medicines and capecitabine‐based chemotherapy for colorectal cancer treatment: A meta‐analysis	16
The heterogeneous impact of targeted therapy on the prognosis of stage III/IV colorectal cancer patients with different subtypes of TP53 mutations	16
Mutational pattern off homologous recombination repair (HRR)‐related genes in upper tract urothelial carcinoma	16
Autologous stem cell transplantation (ASCT) for acute myeloid leukemia in patients in first complete remission after one versus two induction courses: A study from the ALWP of th	16
Health‐related quality of life at 3 months following head and neck cancer treatment is a key predictor of longer‐term outcome and of benefit from using the patient concerns inventory	16
The quality of life in papillary thyroid microcarcinoma patients undergoing lobectomy or total thyroidectomy: A cross‐sectional study	16
Comparison of sampling methods for next generation sequencing for patients with lung cancer	16
Clinical significance and outcomes of bilateral and unilateral recurrent laryngeal nerve lymph node dissection in esophageal squamous cell carcinoma: A large‐scale retrospective cohort study	16
Impact of race/ethnicity and language preferences on pediatric ALL survival outcomes	16
Region of origin and cervical cancer stage in multiethnic Hispanic/Latinx patients living in the United States	16
A single‐center retrospective analysis of prognoses in patients with melanoma brain metastases and effectiveness of treatment in Japan	16
Expansion of the quality of care index on breast cancer and its risk factors using the global burden of disease study 2019	16
Addition of immune checkpoint inhibitors to chemotherapy versus chemotherapy alone in patients with triple‐negative breast cancer: A systematic review and meta‐analysis	16
Perception and safety analysis of COVID‐19 vaccination in cancer patients: A multicenter, real‐world study	16
Impact of body mass index on perioperative and oncological outcomes in elderly patients undergoing minimally invasive McKeown esophagectomy for esophageal squamous cell carcinoma	16
Standard versus low‐dose nab‐paclitaxel in previously treated patients with advanced non‐small cell lung cancer: A randomized phase II trial (JMTO LC14‐01)	16
Regional and racial disparity in proximal gastric cancer survival outcomes 1996–2016: Results from SEER and China National Cancer Center database	16
Mutation patterns and evolutionary action score of TP53 enable identification of a patient population with poor prognosis in advanced non‐small cell lung cancer	16
Baseline cardiac function checkup in patients with gastric or breast cancer receiving trastuzumab or anthracyclines	16
Efficacy and outcome of molecular targeted therapies in elderly patients with hepatocellular carcinoma: Relative dose intensity associated with overall survival	16
Anatomic prognostic factors and their potential roles in refining M1 classification for de novo metastatic nasopharyngeal carcinoma	16
βIII‐tubulin suppression enhances the activity of Amuvatinib to inhibit cell proliferation in c‐Met positive non‐small cell lung cancer cells	16
Association between a single nucleotide polymorphism in the R3HCC1 gene and irinotecan toxicity	16
Identification of FDFT1 as a potential biomarker associated with ferroptosis in ccRCC	16
Mixed reality navigation training system for liver surgery based on a high‐definition human cross‐sectional anatomy data set	16
Thyroid dysfunction and breast cancer risk among women in the UK Biobank cohort	16
Piloting HealthScore: Feasibility and acceptability of a clinically integrated health coaching program for people living with cancer	16
Comparative prognostic value of different preoperative complete blood count cell ratios in patients with oral cavity cancer treated with surgery and postoperative radiotherapy	16
Get insight into the cause of death distribution and epidemiology of penile squamous cell carcinoma: A population‐based study	15
Referral process to further evaluate poor sleep in breast cancer survivors	15
Human papillomavirus testing on self‐collected samples to detect high‐grade cervical lesions in rural Bhutan: The REACH‐Bhutan study	15
Reconstructing spleno‐mesenterico‐portal cofluence by bifurcated allogeneic vein in local advanced pancreatic cancer—a feasible method to avoid left‐sided portal hypertension	15
Comparison of outcomes following lobectomy, segmentectomy, and wedge resection based on pathological subtyping in patients with pN0 invasive lung adenocarcinoma ≤1 cm	15
Adolescent and young adult (AYA) oncology: A credentialed area of focused competence in Canada	15
Hepatic failure associated with immune checkpoint inhibitors: An analysis of the Food and Drug Administration Adverse Event Reporting System database	15
Immunotherapy combined with antiangiogenic therapy as third‐ or further‐line therapy for stage IV non‐small cell lung cancer patients with ECOG performance status 2: A retrospect	15
The metastasis patterns and their prognostic features in patients with de novo metastatic breast cancer of different ages	15
Mirabegron improves the irritative symptoms caused by BCG immunotherapy after transurethral resection of bladder tumors	15
Perioperative opioids and survival outcomes in resectable head and neck cancer: A systematic review	15
Cognitive changes and brain connectomes, endocrine status, and risk genotypes in testicular cancer patients–A prospective controlled study	15
Incidence of pneumonitis following the use of different anaplastic lymphoma kinase tyrosine kinase inhibitor regimens: An updated systematic review and meta‐analysis	15
Issue Information	15
Cost‐effectiveness of second‐line ipilimumab for metastatic melanoma: A real‐world population‐based cohort study of resource utilization	15
High recurrence of lymphedema and influencing factors in discharged breast cancer patients during the COVID‐19 pandemic: A multicenter, cross‐sectional survey	15
A second‐generation CD38‐CAR‐T cell for the treatment of multiple myeloma	15
Performance of cervical cancer screening and triage strategies among women living with HIV in China	15
Interactive effects of molecular subtypes with tumor size and extracranial metastatic pattern on risk of brain metastasis in breast cancer patients: A population‐based study	15
Patterns and predictors of cancer‐specific patient health portal usage among patients with cancer: results from the UWCCC Survivorship Program	15
Temporal increase in the incidence of anal squamous cell carcinoma in Kentucky and factors associated with adverse outcomes	15
Changes in parents' psychotropic medication use following child's cancer diagnosis: A fixed‐effects register‐study in Finland	15
Accuracy of curability expectations in patients with gastrointestinal cancers	15
Issue Information	15
Genetic associations of leisure sedentary behaviors and the risk of 15 site‐specific cancers: A Mendelian randomization study	15
Design and implementation of an Internet‐Based cancer risk assessment tool: Use over 10 years	15
Effect of local treatment in patients with oligo‐recurrence after surgery of distal bile duct cancer: A bi‐institutional study	15
Molecular profiling of colorectal cancer in a genetically admixed Hispanic population	15
	15
Current perspectives of cardio‐oncology: Epidemiology, adverse effects, pre‐treatment screening and prevention strategies	15
An online randomised controlled trial of prognosticating imminent death in advanced cancer patients: Clinicians give greater weight to advice from a prognostic algorithm than from another clinician wi	15
Psychological states and needs among post‐allogeneic hematopoietic stem cell transplantation survivors	15
eEF1A1 promotes colorectal cancer progression and predicts poor prognosis of patients	15
Construction and validation of a novel aging‐related gene signature and prognostic nomogram for predicting the overall survival in ovarian cancer	15
Withdrawal Notice	15
Comorbidity, lifestyle factors, and sexual satisfaction among Chinese cancer survivors	15
Clinical use of lenvatinib in patients with previous renal and/or hepatic impairment and radioiodine‐refractory differentiated thyroid cancer	14
Hepatic arterial infusion chemotherapy, lenvatinib plus programmed cell death protein‐1 inhibitors: A promising treatment approach for high‐burden hepatocellular carcinoma	14